Though CMC barriers remain, strategic planning in the early development stages can guide a CGT product to success.
On November 20, 2025, BioDlink (Stock Code: 1875.HK), a leading biologics CDMO, together with Lepu Biopharma (2157.HK), announced the successful market launch of MEIYOUHENG®(Becotatug Vedotin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback